,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2013-12-18 03:17:00,"Boston Scientific Corporation ( BSX ) announced receipt of the CE Mark approval of its X4 line of quadripolar CRT-D systems, including the AUTOGEN X4, DYNAGEN X4, and INOGEN X4 cardiac resynchronization therapy defibrillators (CRT-Ds), a suite of ACUITY X4 quadripolar LV leads and the ACUITY PRO lead delivery system.",0.7358684539794922,0.010080709122121334,0.2540508508682251,positive,0.7257877588272095
1,2013-12-18 03:17:00,Leads are the wires that connect defibrillators and pacemakers to the heart.,0.03530417010188103,0.010155008174479008,0.9545408487319946,neutral,0.025149162858724594
2,2013-12-18 03:17:00,The ACUITY X4 suite of quadripolar LV leads is uniquely designed with multiple electrode spacing configurations to accommodate individual patient anatomy.,0.2165353000164032,0.006170058622956276,0.7772946357727051,neutral,0.21036523580551147
3,2013-12-18 03:17:00,The 3D spiral further maximizes electrode contact with the myocardium and minimizes pacing capture thresholds in non-apical locations.,0.2905976176261902,0.009861578233540058,0.6995407938957214,neutral,0.2807360291481018
4,2013-12-18 03:17:00,"More importantly, the multiple fixation option of the device assist the medical professionals reach the difficult vessels, which were inaccessible till now, by other available quadripolar leads.",0.7069638967514038,0.013801292516291142,0.27923476696014404,positive,0.6931626200675964
5,2013-12-18 03:17:00,"Extensive observation and research done by the World Health Organization (WHO), has led to the finding that 80% of the premature heart disease and stroke is preventable.",0.6138752102851868,0.01987180858850479,0.36625298857688904,positive,0.5940033793449402
6,2013-12-18 03:17:00,"Therefore, it is believed that that the new offering will act as a boon for the patients and help save lives.",0.8779131770133972,0.014635507948696613,0.10745131224393845,positive,0.8632776737213135
7,2013-12-18 03:17:00,The vital approval opens the scope for commercialization of the medical device across Europe.,0.9063472151756287,0.012954581528902054,0.08069818466901779,positive,0.8933926224708557
8,2013-12-18 03:17:00,It is believed that the Cardiac Rhythm Management (CRM) business of the company will considerably gain from the new approval as the segment is slowly returning to growth.,0.9459519386291504,0.014630426652729511,0.03941766917705536,positive,0.9313215017318726
9,2013-12-18 03:17:00,"The first implant of the AUTOGEN X4 CRT-Ds was successfully accomplished in Civili Hospital, Brescia, Italy.",0.494672030210495,0.010171680711209774,0.4951562285423279,neutral,0.48450034856796265
10,2013-12-18 03:17:00,"According to the WHO, Cardiovascular disease (CVD) account for more than half of all deaths across the European Region.",0.04067600518465042,0.23901957273483276,0.7203044295310974,neutral,-0.19834357500076294
11,2013-12-18 03:17:00,The CE Mark ensures wide recognition of the product throughout the European region.,0.6620307564735413,0.011211109347641468,0.32675817608833313,positive,0.6508196592330933
12,2013-12-18 03:17:00,The important approval is also expected to enhance greater adoption as both medical professionals and patients can rely on the effectiveness of the product.,0.9357467293739319,0.015120753087103367,0.049132537096738815,positive,0.9206259846687317
13,2013-12-18 03:17:00,"Boston Scientific further announced that following the CE mark, it plans to start a global clinical study of the same covering 1000 patients.",0.5017737150192261,0.009503504261374474,0.4887227714061737,positive,0.49227020144462585
14,2013-12-18 03:17:00,"Currently, the stock carries a Zacks Rank #2 (Buy).",0.29884102940559387,0.01109377946704626,0.6900652050971985,neutral,0.28774726390838623
15,2013-12-18 03:17:00,"Investors interested in the medical products industry can look into stocks like Hill-Rom Holdings, Inc. ( HRC ), NuVasive, Inc. ( NUVA ) and Mead Johnson Nutrition Co. ( MJN ).",0.08217884600162506,0.00762486457824707,0.9101962447166443,neutral,0.07455398142337799
16,2013-12-18 03:17:00,"While Hill-Rom sports a Zacks Rank #1 (Strong Buy), NuVasive and Mead Johnson holds a Zacks Rank #2 (Buy).",0.3869820237159729,0.04416007176041603,0.5688579678535461,neutral,0.34282195568084717
17,2013-12-18 03:17:00,To read this article on Zacks.com click here.,0.017961200326681137,0.01924508437514305,0.9627937078475952,neutral,-0.001283884048461914
18,2013-12-18 03:17:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
